Peter Meade Anderson (MD, PhD) graduated summa cum laude from the University of Minnesota and received a PhD in biomedical sciences (medical genetics) from City University of New York and MD from Mt. Sinai School of Medicine. He is board-certified in pediatrics, internal medicine, and pediatric hematology/oncology. He is an Associate Professor at University of Minnesota and a Professor at Mayo Clinic, University of Texas, MD Anderson Cancer Center, and most recently the Cleveland Clinic. His current interests include the use of glutamine and trehalose (Healios) to reduce mucositis and enteritis, virtual visits and online consultations to facilitate multidisciplinary care and toxicity reduction, and the cancer-specific genetics of tumors (e.g., fusion genes and frame-shift mutations), especially for future immune therapies of cancer. Dr. Anderson is currently Chair of the Cleveland Clinic Pharmacy & Therapeutic Committee. He has additional expertise in new drug development and clinical trial regulatory issue,s including single-patient and investigator-initiated INDs.